Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial
Аннотация
Publication date: November 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 11 Author(s): Nadine Rouphael, Shahida Baqar, Michelle Dickey, Christina Quigley, Tena Pham, Josh Adams, Gaurav Kwatra, Sarah Bechnak, Veronica Smith, Erin M Scherer, Daniel S Graciaa, Jill El-Khorazaty, Jamie A Fraser, Susan Heard, Krista Cato, Jorge Mejia-Galvis, Shoshana Barnoy, Lakshmi Chandrasekharan, Chad K Porter, Akamol E Suvarnapunya